Patents by Inventor Frederick Albert SCHROEDER

Frederick Albert SCHROEDER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITING HISTONE DEACETYLASE 6
    Publication number: 20260102395
    Abstract: Provided herein are methods of treating a subject with compounds that inhibit HDAC6, including methods of treating a variety of diseases including neurological disorders.
    Type: Application
    Filed: October 14, 2025
    Publication date: April 16, 2026
    Applicant: Eikonizo Therapeutics, Inc.
    Inventors: Tonya Marie Gilbert, Thomas Edward Richardson, Lauren Taylor Evans, Rebecca Ellen James, Frederick Albert Schroeder, Jianhong Wang, Florence Fevrier Wagner
  • Imaging histone deacetylases with a radiotracer using positron emission tomography
    Patent number: 12491270
    Abstract: Disclosed herein are histone deacetylase imaging agents for positron emission tomography and related imaging methods using the histone deacetylase imaging agents. The histone deacetylase imaging agents may be a compound of formula (I): wherein R1 is a moiety including a positron emitter; R2 represents hydrogen, or substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and n is an integer selected from 0 or 1. In one version of the compound of formula (I), R1 is a moiety including an adamantyl group.
    Type: Grant
    Filed: October 9, 2020
    Date of Patent: December 9, 2025
    Assignee: The General Hospital Corporation
    Inventors: Jacob M. Hooker, Changning Wang, Frederick Albert Schroeder
  • IMAGING HISTONE DEACETYLASES WITH A RADIOTRACER USING POSITRON EMISSION TOMOGRAPHY
    Publication number: 20210030899
    Abstract: Disclosed herein are histone deacetylase imaging agents for positron emission tomography and related imaging methods using the histone deacetylase imaging agents. The histone deacetylase imaging agents may be a compound of formula (I): wherein R1 is a moiety including a positron emitter; R2 represents hydrogen, or substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and n is an integer selected from 0 or 1. In one version of the compound of formula (I), R1 is a moiety including an adamantyl group.
    Type: Application
    Filed: October 9, 2020
    Publication date: February 4, 2021
    Inventors: Jacob M. Hooker, Changning Wang, Frederick Albert Schroeder
  • Imaging histone deacetylases with a radiotracer using positron emission tomography
    Patent number: 10842891
    Abstract: Disclosed herein are histone deacetylase imaging agents for positron emission tomography and related imaging methods using the histone deacetylase imaging agents. The histone deacetylase imaging agents may be a compound of formula (I): wherein R1 is a moiety including a positron emitter; R2 represents hydrogen, or substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and n is an integer selected from 0 or 1. In one version of the compound of formula (I), R1 is a moiety including an adamantyl group.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: November 24, 2020
    Assignee: The General Hospital Corporation
    Inventors: Jacob M. Hooker, Changning Wang, Frederick Albert Schroeder
  • IMAGING HISTONE DEACETYLASES WITH A RADIOTRACER USING POSITRON EMISSION TOMOGRAPHY
    Publication number: 20190240357
    Abstract: Disclosed herein are histone deacetylase imaging agents for positron emission tomography and related imaging methods using the histone deacetylase imaging agents. The histone deacetylase imaging agents may be a compound of formula (I): wherein R1 is a moiety including a positron emitter; R2 represents hydrogen, or substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and n is an integer selected from 0 or 1. In one version of the compound of formula (I), R1 is a moiety including an adamantyl group.
    Type: Application
    Filed: December 7, 2018
    Publication date: August 8, 2019
    Inventors: Jacob M. Hooker, Changning Wang, Frederick Albert Schroeder
  • Imaging histone deacetylases with a radiotracer using positron emission tomography
    Patent number: 10188756
    Abstract: Disclosed herein are histone deacetylase imaging agents for positron emission tomography and related imaging methods using the histone deacetylase imaging agents. The histone deacetylase imaging agents may be a compound of formula (I): wherein R1 is a moiety including a positron emitter; R2 represents hydrogen, or substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and n is an integer selected from 0 or 1. In one version of the compound of formula (I), R1 is a moiety including an adamantyl group.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: January 29, 2019
    Assignee: The General Hospital Corporation
    Inventors: Jacob M. Hooker, Changning Wang, Frederick Albert Schroeder
  • IMAGING HISTONE DEACETYLASES WITH A RADIOTRACER USING POSITRON EMISSION TOMOGRAPHY
    Publication number: 20160271276
    Abstract: Disclosed herein are histone deacetylase imaging agents for positron emission tomography and related imaging methods using the histone deacetylase imaging agents. The histone deacetylase imaging agents may be a compound of formula (I): wherein R1 is a moiety including a positron emitter; R2 represents hydrogen, or substituted or unsubstituted alkyl, or substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and n is an integer selected from 0 or 1. In one version of the compound of formula (I), R1 is a moiety including an adamantyl group.
    Type: Application
    Filed: October 17, 2014
    Publication date: September 22, 2016
    Inventors: Jacob M. HOOKER, Changning WANG, Frederick Albert SCHROEDER